PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDeltex Medical Regulatory News (DEMG)

Share Price Information for Deltex Medical (DEMG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.115
Bid: 0.11
Ask: 0.12
Change: 0.00 (0.00%)
Spread: 0.01 (9.091%)
Open: 0.115
High: 0.115
Low: 0.115
Prev. Close: 0.115
DEMG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

23 Dec 2013 13:40

RNS Number : 2475W
Deltex Medical Group PLC
23 December 2013
 
Deltex Medical Group plc

 

Directors' Shareholdings/Issue of equity

 

 

23 December 2013 Deltex Medical Group plc ("Deltex Medical" or the "Company"), the global leader in oesophageal Doppler monitoring ("ODM"), announces that it has issued a total of 790,574 new ordinary shares of 1p each in the Company ("New Ordinary Shares") at a price of 14.00 pence per share.

 

The four non-executive directors named below have elected to take New Ordinary Shares in lieu of a cash payment as remuneration for their services to the Company for the period 1 October 2012 to 31 December 2013.

 

Paul Mitchell, Finance Director has elected to take New Ordinary Shares in lieu of £20,000 of salary in respect of the period 1 January 2013 to 31 December 2013.

 

In addition to the above, the Company also announces that it has today issued a total of 71,429 New Ordinary Shares to a former employee of the Company at a price of 14.00 pence per share in settlement of contractual obligations.

 

Accordingly, application has been made for these New Ordinary Shares to be admitted to trading on AIM. The shares rank pari passu with the existing issued shares of the Company and dealings are expected to commence on 31 December 2013. Following the issue of these new shares the Company has a total of 168,070,379 ordinary shares of 1p each in issue.

 

Following this issue, the directors' beneficial interests are as follows:

 

 

Name of Director

Number of New Ordinary Shares issued in lieu of fees/salary

 

Holding of shares following issue of New Ordinary Shares

 

% of enlarged issued share capital

Nigel Keen

297,616

6,985,163

4.16

Dr Edwin Snape

214,286

1,430,624

0.85

Sir Duncan Nichol

75,000

928,916

0.55

Julian Cazalet

49,386

4,080,268

2.43

Paul Mitchell

82,857

352,831

0.21

 

For further information:

 

Deltex Medical Group plc

01243 774 837

investorinfo@deltexmedical.com

Nigel Keen, Chairman

 

Ewan Phillips, Chief Executive

 

Paul Mitchell, Finance Director

 

 

 

Nominated Adviser & Broker

Arden Partners plc

020 7614 5900

Chris Hardie

Financial Public Relations

Newgate Threadneedle

020 7653 9850

Graham Herring

Caroline Evans-Jones

Heather Armstrong

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFEIFDDFDSEDE
Date   Source Headline
25th Sep 20177:00 amRNSShare Options
21st Sep 20177:00 amRNSRelease and first sale of HD-ICG in France
11th Sep 20177:00 amRNSInterim Results
31st Aug 20177:00 amRNSNotice of Interim Results
31st Aug 20177:00 amRNSInvestor Event
2nd Aug 201712:59 pmRNSHolding(s) in Company
28th Jul 201711:10 amRNSHolding(s) in Company
27th Jul 20175:24 pmRNSHolding(s) in Company
21st Jul 20177:01 amRNSShare placing
21st Jul 20177:00 amRNSPre-close Trading Update
13th Jun 20179:30 amRNSDirector/PDMR Shareholding
9th Jun 20171:25 pmRNSResult of AGM
9th Jun 20177:00 amRNSExcellent Results from New Trial
9th Jun 20177:00 amRNSAGM Statement
31st May 20177:00 amRNSPatent Grant
26th May 20177:00 amRNSLaunch of ODMV+ system for veterinary anaesthesia
4th May 20177:00 amRNSNew Functionality on CardioQ-ODM+ Monitor Platform
3rd May 20172:20 pmRNSExercise of Options
3rd May 20172:15 pmRNSPublication of Annual Report & Notification of AGM
27th Apr 20177:01 amRNSDeltex awarded EU Horizon 2020 Phase 1 grant
27th Apr 20177:00 amRNSResults for the year ended 31 December 2016
20th Apr 201712:25 pmRNSInvestor open day and notice of results
4th Apr 201711:51 amRNSExercise of Options
28th Mar 20176:05 pmRNSHolding(s) in Company
22nd Mar 20177:15 amRNSGrant of Options
22nd Mar 20177:00 amRNSShare Issues
23rd Feb 20177:00 amRNSNew Monitor Sales in USA and UK
25th Jan 20177:00 amRNSSouth Korean broadens ODM reimbursement
18th Jan 20177:00 amRNSTwo additional US platform programme accounts
18th Jan 20177:00 amRNSTrading Update
30th Nov 20167:00 amRNSAdditional US platform programme account
4th Nov 20167:00 amRNSNHS hospital invests in ODM equipment
8th Sep 20167:00 amRNSThree new US platform programme accounts
8th Sep 20167:00 amRNSInterim results
15th Aug 201611:10 amRNSHolding(s) in Company
15th Jul 20164:00 pmRNSHolding(s) in Company
11th Jul 20167:00 amRNSResults from head to head trial presented
8th Jul 20167:00 amRNSPre-close Trading Update
1st Jul 20168:19 amRNSShare Subscription
17th Jun 20164:10 pmRNSDirector/PDMR Shareholding
9th Jun 20167:00 amRNSTwo new accounts added to US platform programme
1st Jun 20167:00 amRNSODM adopted into clinical guidelines in Spain
12th May 20161:10 pmRNSResult of AGM
12th May 20169:30 amRNSDirector/PDMR Shareholding
12th May 20167:01 amRNSTwo US accounts added to platform programme
12th May 20167:00 amRNSAGM Statement
4th May 20167:00 amRNSEnhanced performance TruFlow probe launched in UK
20th Apr 20163:25 pmRNSPosting of Annual Report and Notice of AGM
5th Apr 20167:00 amRNSTwo new US platform programme accounts opened
10th Mar 20167:00 amRNSPlacing and Issue of Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.